findmyKOL
Clinical trialNCT05327231CompletedPhase 1Interventional

IN10018 Monotherapy or in Combination With Docetaxel in Gastric or GEJ Adenocarcinoma

SponsorInxMed (Shanghai) Co., Ltd.Enrollment33Gastric Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • Anyang Tumor Hospital

    Anyang, Henan, China

  • Henan Cancer Hospital

    Zhengzhou, Henan, China

  • the First Affiliated Hospital of Zhengzhou University

    Zhengzhou, Henan, China

  • the Affiliated Hospital of Nanjing University Medical School

    Nanjing, Jiangsu, China

  • the First Hospital of China Medical University

    Shenyang, Liaoning, China

  • Shanghai East Hospital

    Shanghai, Shanghai Municipality, China

  • the First Affiliated Hospital of Xi 'An Jiaotong University

    Xi’an, Shanxi, China

  • Tianjin Medical University Cancer Institute & Hospital

    Tianjin, Tianjin Municipality, China

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
9 Jul 2020
Primary completion
3 Dec 2021
Completion
31 Mar 2022
Last update posted
16 Nov 2022
Registered enrollment
33
Registry id
NCT05327231

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.